Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

GeroScience(2021)10.1007/s11357-021-00471-6Source: DataRank Database

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans is a research paper published in GeroScience (2021). On theSindex it has a DataRank of 0. It has been cited 83 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access83 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.77)OA: hybridTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Zsolt Matula ORCID,Márton Gönczi,Szabolcs Tasnády ORCID,Gabriella Bekő,Marienn Réti ORCID

Live enrichment

PubMed:34633612 PMC:PMC8503874 OpenAlex:https://openalex.org/W3204989207

Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Grant: 2020-1.1.6-JÖVŐ-2021-00011

Center for Information Technology

Grant: EFOP-1.8.0-VEKOP-17-2017-00001

FWCI

4.77

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11357-021-00471-6.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11357-021-00471-6.pdf

publisherhttps://link.springer.com/article/10.1007/s11357-021-00471-6/fulltext.html

journalhttps://doi.org/10.1007/s11357-021-00471-6

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34633612

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmunotherapy and Immune ResponsesBNT162 VaccineCOVID-19COVID-19 VaccinesHumansSARS-CoV-2T-LymphocytesVaccines

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineHumansT-LymphocytesVaccines

Keywords

Immune systemAntibody responseAntibodyVirologyVirusVaccinationEpitopeImmunologyMedicineImmunityBiologyadaptive immunityAnti-sars-cov-2 AntibodiesIfnγ Elispot AssayIfnγ-producing T Cells

Sustainable Development Goals

SDG 0: Good health and well-being